Anticancer agent 135 (compound 26h) is a potent androgen receptor (AR) antagonist that blocks AR nuclear translocation and inhibits AR/AR-V7 heterodimerization to suppress downstream gene transcription, demonstrating strong efficacy in prostate cancer xe
Molecular Weight:
458.5
Formula:
C23H21F3N4OS
Target:
Androgen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted